MT Pharma

Active

Private limited companyfounded 2023active for 3 yearsChemin de Flory Champ 9, 6860 Léglise, BelgiumKBO/BCE: BE 1000.033.178

Summary

The computed 12-month bankruptcy probability of MT Pharma is 2.0% (moderate). The 2025 annual accounts show negative equity (-€47,943) and a net result of -€33,835. Its solvency ranks better than 11% of 12,482 sector peers (NACE 47, financial year 2025). The company has been active since 2023 and the Belgian Official Gazette contains no insolvency or warning signals.

Risk analysisFollow Report Compare

MT PharmaActiveChecked score 52/100

Risk analysis Report Compare

History

MT Pharma was incorporated on 19 September 2023 as a private limited company.¹ The company has filed 2 sets of annual accounts, the latest for financial year 2025.²

Acts, filings and financial milestones

All 2Filings 2

Next filing, financial year 2026, expected by 31-07-2027

2026

24-07

NBB filing Annual accounts filed

financial year 2025 · abbreviated format

2025

31-07

NBB filing Annual accounts filed

financial year 2024 · full format

NBB filing

0 of 1 deed read

About the unread acts

We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.